-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Necrotal pneumonia (NP) is a new complication of community-acquired pneumonia (CAP) in children.
the study aims to evaluate the etiology, clinical characteristics, treatment and prognosis of NP.
researchers searched the institutional database of CAP children treated between April 2008 and July 2013 to identify NP-affected children.
then, the NP feature data are reviewed and analyzed retrospectively.
found that NP accounted for 32/882 (3.7%) of all Caps. The median age of children with
NP is 4 years (range 1-10 years).
identified pathogenic bacteria in 12/32 children (37.5%) of whom Streptococcus pneumoniae was the most common (6/32).
all but one patient developed complications: pneumoconiosis fluid (PPE), pleural emphysema, or bronchial pleural fistula (BPF), requiring timely local treatment. the median time for
hospitalization and antibiotic treatment was 26 (IQR 21-30) days and 28 (IQR 22.5-32.5) days, respectively.
, despite the severity of the illness, no deaths have occurred.
follow-up six months later showed no symptoms or signs that might be associated with early pneumonia.
chest X-rays showed that lung and chest lesions in all patients were completely or almost completely gone.
the above, the results show that necrotised pneumonia is a relatively rare but severe form of CAP, almost always concurrent PPE/emphysema and/or BPF.
it can be successfully treated with antibiotics and pleural drainage without the need for major surgical interventions.
.